We have shown that HDAC8 and ALK pathways converge at downstream nodes, and that simultaneous inhibition of HDAC8 and the RTK-ERK pathway leads to efficient cell death of neuroblastoma cells (model Fig. 7g). This evidence concerns the gene EPHB2 and neuroblastoma.